IONS Q4 2019 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$494M+157.0% YoY

Gross Profit

$493M99.8% margin

Operating Income

$261M52.8% margin

Net Income

$184M37.4% margin

EPS (Diluted)

$1.28

QoQ Revenue Growth

+194.0%

Cash Flow

Operating Cash Flow

$278M

Free Cash Flow

$269M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$3.2B

Total Liabilities

$1.5B

Stockholders' Equity

$1.5B

Cash & Equivalents

$683M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$494M	$192M	+157.0%
Gross Profit	$493M	$77M	+541.1%
Operating Income	$261M	$11M	+2316.8%
Net Income	$184M	$320M	-42.4%